N@N

Zynex, Inc. to Exhibit at MEDICA 2011-World Forum for Medicine International Trade Fair

^{Published on 2011-08-22 05:12:37 - Market Wire}
 

LONE TREE, Colo.--([ BUSINESS WIRE ])--Zynex, Inc. (OTCBB: [ ZYXI ]), a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced that it will be exhibiting at the upcoming MEDICA 2011-World Forum for Medicine International Trade Fair being held on November 16-19, 2011 in Dusseldorf, Germany.

"The MEDICA trade fair brings together a large informed world audience within the medical industry. We believe our participation in this event will help us advance our efforts to expand our global reach."

The MEDICA trade fair is the worlda™s largest forum for in-patient and out-patient medicine and is the hub of international medical trade. MEDICA features over 4,400 exhibitors from around the world and is expected to draw more than 138,000 visitors from over 100 countries. For more information, please visit: [ http://www.mdna.com ].

Thomas Sandgaard, CEO stated, aThe MEDICA trade fair brings together a large informed world audience within the medical industry. We believe our participation in this event will help us advance our efforts to expand our global reach.a

About Zynex

Zynex, Inc. (founded in 1996), operates under three primary business segments; Zynex Medical, Zynex NeuroDiagnostics and Zynex Monitoring Solutions. Zynex Medical engineers, manufactures, markets and sells its own design of electrotherapy medical devices for standard digital electrotherapy, used for pain relief, pain management and stroke and spinal cord injury rehabilitation. Zynex Medicala™s product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's [ mission ] of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex NeuroDiagnostics, currently in the development stage, has been established to market EMG, EEG, sleep pattern, auditory and nerve conductivity neurological diagnosis devices through product development or acquisitions. Zynex Monitoring Solutions, currently in the development stage, has been established to develop and market medical devices for non-invasive cardiac monitoring.

For additional information please visit: [ http://www.ir-site.com/zynex/default.asp ].

Safe Harbor Statement

Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage additional sales representatives, the success of such additional sales representatives, the need to obtain FDA clearance and CE marking of new products, the acceptance of new products as well as existing products by doctors and hospitals, larger competitors with greater financial resources, the need to keep pace with technological changes, our dependence on the reimbursement from insurance companies for products sold or rented to our customers, acceptance of our products by health insurance providers, our dependence on third party manufacturers to produce our goods on time and to our specifications, implementation of our sales strategy including a strong direct sales force, the uncertain outcome of pending material litigation and other risks described in our filings with the Securities and Exchange Commission including the aRisk Factorsa section of our Annual Report on Form 10-K for the year ended December 31, 2010.